Brief: Medrx signs drug development and sale contract with Cipla USA Inc
06/04/2017 07:44
April 6 (Reuters) - Medrx Co Ltd 4586.T :
* Says the company enters into a license contract with an
India-based pharma Cipla Ltd's wholly owned US-based unit Cipla
USA Inc, on development and sale of MRX-4TZT, transdermal patch
for the treatment of spastic paralysis
Source text in Japanese: https://goo.gl/8LUJTd
Further company coverage: 4586.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724;
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))